Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effects of Sensorimotor Balance Training vs Digitally Augmented Core Stabilization in Women With Osteoporosis

17. november 2026 oppdatert av: Riphah International University

Effects of Sensorimotor-Based Balance Training Versus Digitally Augmented Core Stabilization on Postural Control and Fall Risk in Postmenopausal Women With Osteoporosis

This randomized controlled trial aims to compare the effects of sensorimotor-based balance training and digitally augmented core stabilization on postural control and fall risk in postmenopausal women with osteoporosis. Osteoporosis is a common condition in postmenopausal women that can impair balance, reduce functional mobility, and increase the risk of falls and fractures. Eligible participants will be randomly assigned to one of two intervention groups. Group A will receive a structured sensorimotor-based balance training program, while Group B will receive a digitally augmented core stabilization exercise program supported through the HEP2Go platform and monitored via WhatsApp. Both groups will receive supervised physiotherapy sessions three times per week for 8 weeks. Outcome measures including postural control, fall risk, spinal alignment, core muscle endurance, proprioception, muscle strength, adherence, and usability will be assessed before and after the intervention. The findings of this study may provide evidence regarding effective physiotherapy strategies for improving balance and reducing fall risk in postmenopausal women with osteoporosis.

Studieoversikt

Detaljert beskrivelse

Osteoporosis is a progressive skeletal disorder characterized by reduced bone mineral density and deterioration of bone microarchitecture, resulting in increased bone fragility and susceptibility to fractures. Postmenopausal women are particularly affected because estrogen deficiency accelerates bone loss, leading to impaired postural stability, reduced muscle strength, proprioceptive deficits, and an increased risk of falls. Falls are a major cause of morbidity, disability, and reduced quality of life among women with osteoporosis.

Exercise-based physiotherapy is an important non-pharmacological intervention for improving balance, postural control, muscle strength, and functional mobility in individuals with osteoporosis. Sensorimotor-based balance training aims to improve proprioception, neuromuscular coordination, and postural stability through progressively challenging balance and functional activities. Core stabilization exercises focus on strengthening deep trunk muscles to improve spinal stability, posture, and movement control.

Digital rehabilitation technologies have increasingly been incorporated into physiotherapy practice to improve exercise adherence, accessibility, and patient engagement. In this study, digital augmentation will be delivered through the HEP2Go platform by providing individualized home exercise programs with exercise illustrations and written instructions. Participants in the digitally augmented group will also receive regular follow-up and adherence monitoring through WhatsApp communication with the assistance of caregivers.

This study will be conducted as a randomized controlled trial involving postmenopausal women diagnosed with osteoporosis. Eligible participants who satisfy the inclusion criteria and provide written informed consent will undergo baseline assessment and then be randomly allocated to one of two intervention groups. Group A will receive a structured sensorimotor-based balance training program, whereas Group B will receive a digitally augmented core stabilization exercise program. Both interventions will be administered three times per week for 8 weeks.

Primary outcomes include postural control and fall risk. Secondary outcomes include thoracic kyphosis angle, core muscle endurance, lumbar joint position sense, trunk extensor strength, exercise adherence, and system usability. Outcome measures will be recorded before and after completion of the intervention using standardized assessment tools. Data will be analyzed using SPSS version 26 to compare within-group and between-group changes.

Studietype

Intervensjonell

Registrering (Antatt)

40

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

  • Navn: Hadia D/O Shahid Hassan Siddiqui, DPT
  • Telefonnummer: +92 305-5085595
  • E-post: hadiadr2000@gmail.com

Studiesteder

    • Federal
      • Islamabad, Federal, Pakistan, 44000
        • Rekruttering
        • Muhammad Adnan Saeed
        • Ta kontakt med:
          • Muhammad Adnan Saeed, PhD
          • Telefonnummer: +93219565124
          • E-post: dasnmc@gmail.com

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

45 år til 70 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Hunn

Beskrivelse

Inclusion Criteria:

  • PMW diagnosed with osteoporosis through DEXA (T-score ≤ -2.5)
  • Age (45-70 years).
  • Able to participate in sessions and walk independently.
  • Mild to moderate Balance impairment as per BBS

Exclusion Criteria:

  • • Women with severe mobility impairments.

    • History of fragility fracture within the last 6 months
    • Women with cognitive conditions affecting participation.
    • Women with lower limb joint injury or surgery.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Sensorimotor-Based Balance Training

Participants assigned to this arm will receive a structured sensorimotor-based balance training program aimed at improving postural control, proprioception, balance, and reducing fall risk in postmenopausal women with osteoporosis. The intervention consists of warm-up exercises, static and dynamic balance training, sensorimotor and proprioceptive exercises, gait and functional training, lower-limb strengthening exercises, and cool-down activities. Supervised physiotherapy sessions will be conducted three times per week for 8 weeks, with progressive exercise intensity according to participant tolerance.

A supervised sensorimotor-based balance training program comprising progressive static and dynamic balance exercises, proprioceptive training, gait training, lower-limb strengthening, functional balance activities, and cool-down exercises. Sessions will be conducted three times per week for 8-12 weeks to improve postural control, balance, and functional mobility in postmenopausal women with osteoporosis.

Eksperimentell: Digitally Augmented Core Stabilization

Participants assigned to this arm will receive a structured core stabilization exercise program enhanced through digital augmentation using the HEP2Go platform. Individualized home exercise programs containing exercise illustrations and written instructions will be provided through HEP2Go. The intervention includes warm-up, deep core muscle activation, core stabilization exercises, functional core training, postural training, and cool-down exercises. Supervised physiotherapy sessions will be conducted three times per week for 8 weeks. Exercise adherence and progress will be monitored through regular WhatsApp communication with participants and their caregivers.

A supervised core stabilization exercise program focusing on activation and strengthening of deep trunk muscles, postural alignment, and functional stability. Digital augmentation will be provided through the HEP2Go platform by delivering individualized home exercise programs with exercise illustrations and written instructions. Participants will also receive regular WhatsApp reminders, educational support, and adherence monitoring throughout the 8-12-week intervention period.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Postural Control (Mini-BESTest)
Tidsramme: Baseline (pre-intervention) and immediately after completion of the 8-week intervention.

Postural control will be assessed using the Mini-Balance Evaluation Systems Test (Mini-BESTest), a 14-item clinical measure of postural control. Total scores range from 0 to 28 points, with higher scores indicating better postural control.

Baseline (pre-intervention) and immediately after completion of the 8-week intervention.
Fall Risk
Tidsramme: Baseline (pre-intervention) and immediately after completion of the 8-week intervention.

Fall risk will be assessed using the Timed Up and Go (TUG) Test. Time is recorded in seconds, with shorter completion times indicating better functional mobility and lower fall risk.

Baseline (pre-intervention) and immediately after completion of the 8-week intervention.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Thoracic Kyphosis Angle
Tidsramme: Baseline and immediately after completion of the 8-week intervention.

Thoracic kyphosis angle will be measured using a Flexicurve ruler.

Baseline and immediately after completion of the 8-week intervention.
Core Muscle Endurance
Tidsramme: Baseline and immediately after completion of the 8-week intervention

core muscle endurance will be assessed using the Modified McGill Trunk Endurance Test.

Baseline and immediately after completion of the 8-week intervention
Proprioception
Tidsramme: Baseline and immediately after completion of the 8-week intervention.

Lumbar proprioception will be assessed using the lumbar joint position sense repositioning error test.

Baseline and immediately after completion of the 8-week intervention.
Trunk Extensor Muscle Strength
Tidsramme: Baseline and immediately after completion of the 8-week intervention.

Trunk extensor muscle strength will be measured using a handheld dynamometer.

Baseline and immediately after completion of the 8-week intervention.
Exercise Adherence
Tidsramme: Throughout the 8-week intervention period.

Exercise adherence will be evaluated using attendance records and home exercise adherence logs throughout the intervention period.

Throughout the 8-week intervention period.
System Usability
Tidsramme: At the end of the 8-week intervention.

System usability of the digitally augmented intervention will be assessed using the System Usability Scale (SUS). The SUS consists of 10 items and provides a total score ranging from 0 to 100 points, with higher scores indicating better perceived usability of the digitally augmented intervention.

At the end of the 8-week intervention.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Huma Riaz, Riphah International University, Islamabad

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

19. oktober 2026

Primær fullføring (Antatt)

30. juni 2027

Studiet fullført (Antatt)

31. juli 2027

Datoer for studieregistrering

Først innsendt

16. september 2026

Først innsendt som oppfylte QC-kriteriene

11. oktober 2026

Først lagt ut (Faktiske)

15. oktober 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

18. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

17. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data (IPD) will not be shared publicly because the dataset contains confidential participant information collected for an academic research project. Data will be stored securely and used only for the purposes of this study. Any future sharing of de-identified data will require approval from the Institutional Review Board/Ethics Committee and the principal investigator, in accordance with institutional policies and participant consent.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere